Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Entergy Corporation (ETR) vs Indivior Pharmaceuticals Inc. Common Stock (INDV) Price & Performance

Entergy CorporationTrade
Indivior Pharmaceuticals Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Entergy Corporation vs Indivior Pharmaceuticals Inc. Common Stock — how do they compare? Entergy Corporation trades at $103.92 (market cap $50.16B), while Indivior Pharmaceuticals Inc. Common Stock trades at $34.01 (market cap $4.18B). The key difference: Entergy Corporation is far larger — about 12× Indivior Pharmaceuticals Inc. Common Stock's market cap, and Entergy Corporation pays a 2.44% dividend while Indivior Pharmaceuticals Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Entergy Corporation for 13 Days and Indivior Pharmaceuticals Inc. Common Stock for 0 Days on average.

ETRINDV
Market Cap
$50.16B$4.18B
Volume
2,603,9911,819,746
Sector
UtilitiesHealth
52-Week High
$117.91$41.83
52-Week Low
$91.19$24.09
Typical Hold Time
13 Days0 Days
Enterprise Value
$80.94B$4.47B
Dividend Yield
2.44%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Entergy Corporation

Entergy Corporation (ETR) trades at $104.99, up 0.96% with a bullish technical signal despite overbought RSI readings. The stock shows strong fundamentals with 13.48% net margins and consistent earnings beats in recent quarters. Recent developments include $13.7M in federal grid funding and new data center agreements benefiting customers. Analyst consensus remains strongly positive with 59% buy ratings and a $123.17 price target representing 17% upside potential.

ETR presents a compelling investment case with stable utility operations, improving cash flows, and strategic grid investments. However, elevated valuation multiples and institutional selling activity warrant caution. The stock's proximity to resistance at $105 suggests near-term consolidation may precede further gains if earnings momentum continues through Q3 results.

Indivior Pharmaceuticals Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

ETR
0% Buy100% Sell
Avg holding period · 13 Days
INDV
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Entergy Corporation

Entergy is an energy company that operates regulated electric utilities and power generation businesses in the United States. Its generation portfolio includes nuclear, natural gas, and renewable resources.

Read more on ETR →

About Indivior Pharmaceuticals Inc. Common Stock

Indivior Pharmaceuticals, Inc. is a pharmaceutical company focused on treatments for opioid use disorder and other addiction-related conditions, including its Suboxone film and tablet products.

Read more on INDV →